Identification of Novel Oncogenic Signaling Pathways using Viral Perturbations

利用病毒扰动鉴定新型致癌信号通路

基本信息

  • 批准号:
    9816351
  • 负责人:
  • 金额:
    $ 89.55万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-08-08 至 2026-07-31
  • 项目状态:
    未结题

项目摘要

Project Summary Merkel cell carcinoma (MCC) is a primary neuroendocrine carcinoma of the skin; a highly aggressive cancer with a 40% 2-year mortality rate. While the incidence of MCC is 25-fold less frequent than melanoma, it is 13-fold more likely to cause death. In a remarkably short time, MCC has gone from an unknown cancer to the poster child for the success of checkpoint blockade therapy (CBT). With the application of powerful new tools to the study of MCC, it can be expected that the next 7 years will continue to bring remarkable new discoveries with the potential to increase our insight not only into this cancer but into many other cancers as well. There are two forms of MCC with different etiologies but nearly identical presentations. Virus-negative (VN) MCC is caused by excessive sunlight exposure resulting in ultraviolet (UV) induced damage to the genome, a pattern typical for other skin cancers including melanoma, squamous cell carcinoma and basal cell carcinoma. In contrast, virus-positive (VP) MCC is caused by integration of the MCPyV viral DNA into the host cell genome with expression of a truncated form of Large T antigen (LT) and an intact Small T antigen (ST). Despite the near identical phenotypes, VN-MCC and VP-MCC have striking differences in their overall genome mutation rate. The VN-MCC has a much higher tumor mutational burden (TMB, median ~ 40 mutations/mB) than VP-MCC (median 2/mB). VN-MCC has near universal inactivation of the RB1 and TP53 tumor suppressor genes as well as in the lysine methyl transferase genes KMT2C and KMT2D (also known as MLL3 and MLL4). In addition, VN-MCC frequently contains amplification of MYCL or MYC. In contrast, VP- MCC can be recognized by the presence of integrated MCPyV genomes, the absence of UV mutation signature, a low TMB, and few if any mutations. Instead, VP-MCC expresses MCPyV LT that functionally inactivates RB while ST recruits MYCL to the EP400 chromatin modifying complex to induce profound changes in gene expressions. These distinctions between VP-MCC and VN-MCC raises the question of what we can learn about each form of MCC that can inform us about the other. We propose that the distinct mechanisms of oncogenesis in VN-MCC and VP-MCC provides us with the unique opportunity to use orthogonal methodologies to gain a clearer insight into MCC. We propose that expression of MCPyV LT and ST is capable of inducing the relevant phenotypic changes observed in VP-MCC that occur through the inactivating mutations of RB1, TP53, and KMT2C/D genes and amplification of MYCL in VN-MCC. Our cancer program has made remarkable progress in distinguishing between VN-MCC and VP-MCC and is now poised to exploit this opportunity to leverage insights gained from each type of MCC to inform the other that will lead to significant insights into this disease. Furthermore, we expect that these insights will provide useful insights into the oncogenic pathways that contribute to other cancer types.
项目摘要 默克尔细胞癌(MCC)是一种原发性皮肤神经内分泌癌,是一种高度侵袭性的 癌症的两年死亡率为40%。虽然MCC的发病率比黑色素瘤低25倍,但它 导致死亡的可能性要高出13倍。在非常短的时间内,MCC已经从一种未知的癌症发展到 检查点封锁疗法(CBT)成功的典范。随着强大的新技术的应用 工具给MCC的研究,可以预期,未来7年将继续带来令人瞩目的新 有可能增加我们对这种癌症以及许多其他癌症的洞察力的发现 井。有两种形式的MCC,病因不同,但表现几乎相同。病毒阴性 (VN)MCC是由于过度暴露在阳光下导致紫外线(UV)对 基因组,这是其他皮肤癌的典型模式,包括黑色素瘤、鳞状细胞癌和基底细胞癌 癌症。相反,病毒阳性(VP)MCC是由MCPyV病毒DNA整合到宿主中引起的 表达截短形式的大T抗原(LT)和完整的小T抗原(ST)的细胞基因组。 尽管VN-MCC和Vp-MCC的表型几乎相同,但它们在总体上有显著的差异 基因组突变率。VN-MCC的肿瘤突变负荷要高得多(TMB,中位数~40 突变/MB)高于VP-MCC(中位数2/MB)。VN-MCC具有几乎普遍的RB1和TP53失活 肿瘤抑制基因以及赖氨酸甲基转移酶基因KMT2C和KMT2D(也称为 ML3和MLL4)。此外,VN-MCC经常含有MYCL或MYC的扩增。相比之下,副总统- MCC可以通过存在整合的MCPyV基因组、没有紫外线突变来识别 特征,低TMB,以及很少的突变。相反,VP-MCC在功能上表达了MCPyV LT 灭活RB而ST招募MYCL到EP400染色质修饰复合体引发深刻变化 在基因表达上。 VP-MCC和VN-MCC之间的这些区别提出了一个问题,即我们可以对各自了解什么 一种MCC的形式,可以告诉我们关于另一个的情况。我们认为,肿瘤发生的不同机制 VN-MCC和VP-MCC为我们提供了使用正交方法获得 对MCC有更清晰的了解。我们认为MCPyV LT和ST的表达能够诱导相关的 在VP-MCC中观察到的通过RB1、TP53和TP53的失活突变发生的表型变化 VN-MCC中KMT2C/D基因和MYCL基因的扩增我们的癌症项目取得了显著进展 在区分VN-MCC和VP-MCC方面,现在准备利用这一机会利用 从每种类型的MCC中获得的见解将为另一种类型的MCC提供信息,这将导致对这种疾病的重大洞察。 此外,我们希望这些洞察力将为致癌途径提供有用的见解, 会导致其他类型的癌症。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

James A. DeCaprio其他文献

The DREAM complex: master coordinator of cell cycle-dependent gene expression
DREAM 复合物:细胞周期依赖性基因表达的主要协调者
  • DOI:
    10.1038/nrc3556
  • 发表时间:
    2013-07-11
  • 期刊:
  • 影响因子:
    66.800
  • 作者:
    Subhashini Sadasivam;James A. DeCaprio
  • 通讯作者:
    James A. DeCaprio
IMPDH inhibition induces DNA replication stress and ATR sensitivity in Merkel cell carcinoma
IMPDH抑制在默克尔细胞癌中诱导DNA复制应激和ATR敏感性
  • DOI:
    10.1016/j.isci.2025.112567
  • 发表时间:
    2025-06-20
  • 期刊:
  • 影响因子:
    4.100
  • 作者:
    Julia L. Schnabel;Thomas C. Frost;Adam C. Wang;Varsha Ananthapadmanabhan;Satvik Gurram;Kara M. Soroko;Prafulla C. Gokhale;James A. DeCaprio
  • 通讯作者:
    James A. DeCaprio
Epidemiology, biology and therapy of Merkel cell carcinoma: conclusions from the EU project IMMOMEC
  • DOI:
    10.1007/s00262-017-2099-3
  • 发表时间:
    2017-11-30
  • 期刊:
  • 影响因子:
    5.100
  • 作者:
    Jürgen C. Becker;Andreas Stang;Axel zur Hausen;Nicole Fischer;James A. DeCaprio;Richard W. Tothill;Rikke Lyngaa;Ulla Kring Hansen;Cathrin Ritter;Paul Nghiem;Christopher K. Bichakjian;Selma Ugurel;David Schrama
  • 通讯作者:
    David Schrama
Milademetan is a highly potent MDM2 inhibitor in TP53 wild-type (p53 WT) models of Merkel cell carcinoma (MCC)
  • DOI:
    10.1016/j.jid.2022.08.004
  • 发表时间:
    2022-10-01
  • 期刊:
  • 影响因子:
  • 作者:
    Varsha Ananthapadmanabhan;Thomas C. Frost;Kara M. Soroko;Aine Knott;Brianna Magliozzi;Prafulla C. Gokhale;Vijaya Tirunagaru;Robert C. Doebele;James A. DeCaprio
  • 通讯作者:
    James A. DeCaprio
Association between treatment center experience and survival after diagnosis of stage I to III Merkel cell carcinoma treated with surgery with or without postoperative radiation therapy
  • DOI:
    10.1016/j.jaad.2020.10.089
  • 发表时间:
    2021-03-01
  • 期刊:
  • 影响因子:
  • 作者:
    Fallon E. Chipidza;Manisha Thakuria;Jonathan D. Schoenfeld;Ann W. Silk;Paul J. Catalano;Charles H. Yoon;Glenn J. Hanna;James A. DeCaprio;Roy B. Tishler;Danielle N. Margalit
  • 通讯作者:
    Danielle N. Margalit

James A. DeCaprio的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('James A. DeCaprio', 18)}}的其他基金

Identification of Novel Oncogenic Signaling Pathways using Viral Perturbations
利用病毒扰动鉴定新型致癌信号通路
  • 批准号:
    10460971
  • 财政年份:
    2019
  • 资助金额:
    $ 89.55万
  • 项目类别:
Identification of Novel Oncogenic Signaling Pathways using Viral Perturbations
利用病毒扰动鉴定新型致癌信号通路
  • 批准号:
    10411425
  • 财政年份:
    2019
  • 资助金额:
    $ 89.55万
  • 项目类别:
Identification of Novel Oncogenic Signaling Pathways using Viral Perturbations
利用病毒扰动鉴定新型致癌信号通路
  • 批准号:
    10664906
  • 财政年份:
    2019
  • 资助金额:
    $ 89.55万
  • 项目类别:
Identification of Novel Oncogenic Signaling Pathways using Viral Perturbations
利用病毒扰动鉴定新型致癌信号通路
  • 批准号:
    10222618
  • 财政年份:
    2019
  • 资助金额:
    $ 89.55万
  • 项目类别:
CORE 2: Administrative Core
核心 2:行政核心
  • 批准号:
    10227788
  • 财政年份:
    2017
  • 资助金额:
    $ 89.55万
  • 项目类别:
Program Integration
程序整合
  • 批准号:
    9981668
  • 财政年份:
    2017
  • 资助金额:
    $ 89.55万
  • 项目类别:
Young Empowered Scientists for ContinUed Research Engagement (YES for CURE)
赋权年轻科学家继续参与研究(CURE 是)
  • 批准号:
    9416355
  • 财政年份:
    2017
  • 资助金额:
    $ 89.55万
  • 项目类别:
PROJECT 1: Merkel Cell Carcinoma, Merkel Cell Polyomavirus and PP2A (James A. DeCaprio)
项目 1:默克尔细胞癌、默克尔细胞多瘤病毒和 PP2A (James A. DeCaprio)
  • 批准号:
    9981670
  • 财政年份:
    2017
  • 资助金额:
    $ 89.55万
  • 项目类别:
CORE 2: Administrative Core
核心 2:行政核心
  • 批准号:
    9981677
  • 财政年份:
    2017
  • 资助金额:
    $ 89.55万
  • 项目类别:
Human Cancer Suppressor Functions of Protein Phosphatase 2A
蛋白磷酸酶 2A 的人类癌症抑制功能
  • 批准号:
    9981664
  • 财政年份:
    2017
  • 资助金额:
    $ 89.55万
  • 项目类别:

相似海外基金

Evaluating the use of verbal autopsy methods for producing cause of death estimates in Uganda
评估乌干达使用口头尸检方法进行死因估计的情况
  • 批准号:
    2587582
  • 财政年份:
    2021
  • 资助金额:
    $ 89.55万
  • 项目类别:
    Studentship
A research on victim considering cause of death in Miyagi Prefecture in the Great East Japan Earthquake
东日本大地震宫城县受害者死因研究
  • 批准号:
    20K14999
  • 财政年份:
    2020
  • 资助金额:
    $ 89.55万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Improving Communication of Cause of Death and Heritable Heart Disease Risk to Families of Sudden Cardiac Death Victims: A Mixed Methods Study
改善对心脏性猝死受害者家属的死因和遗传性心脏病风险的沟通:一项混合方法研究
  • 批准号:
    437956
  • 财政年份:
    2020
  • 资助金额:
    $ 89.55万
  • 项目类别:
    Operating Grants
Establishing and evaluating minimally invasive autopsy to determine cause of death from infectious disease in Vietnam
建立和评估微创尸检以确定越南传染病死因
  • 批准号:
    MR/R026300/1
  • 财政年份:
    2020
  • 资助金额:
    $ 89.55万
  • 项目类别:
    Research Grant
Population attributable risk estimation for major cause of death associated with family history in Japanese
日本与家族史相关的主要死亡原因的人群归因风险估计
  • 批准号:
    19K24186
  • 财政年份:
    2020
  • 资助金额:
    $ 89.55万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Erroneous Coding of Developmental Disabilities as Underlying Cause of Death
将发育障碍错误编码为潜在死因
  • 批准号:
    10078585
  • 财政年份:
    2020
  • 资助金额:
    $ 89.55万
  • 项目类别:
Identification of genes that influence methamphetamine toxicity and application to cause of death investigation
影响甲基苯丙胺毒性的基因鉴定及其在死因调查中的应用
  • 批准号:
    19K10698
  • 财政年份:
    2019
  • 资助金额:
    $ 89.55万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Bayesian analysis of cause of death assignment using verbal autopsy data
使用口头尸检数据进行死因分配的贝叶斯分析
  • 批准号:
    18K12756
  • 财政年份:
    2018
  • 资助金额:
    $ 89.55万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Symptom normalization for cause of death prediction using machine learning
使用机器学习进行症状标准化以预测死因
  • 批准号:
    526962-2018
  • 财政年份:
    2018
  • 资助金额:
    $ 89.55万
  • 项目类别:
    University Undergraduate Student Research Awards
Development of a method to investigate cause of death related to fatty acid oxidation disorder.
开发一种调查与脂肪酸氧化障碍相关的死亡原因的方法。
  • 批准号:
    18K10118
  • 财政年份:
    2018
  • 资助金额:
    $ 89.55万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了